Product Information
HALOPERIDOL DEC 100 MG/ML VIAL is a generic product labeled by Sagent Pharmaceuticals, priced at $7.5241 per ML under NDC 25021083301. Its NADAC has been published 186 times since Feb 28, 2018.
FDA first approved this application on May 12, 2017. Its Orange Book therapeutic-equivalence code is AO.
Strength
100 mg/mL
Manufacturer
Sagent PharmaceuticalsNDC
25021083301
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
HALOPERIDOL DECANOATEApproval Type
Generic (ANDA)
FDA Application
ANDA205241FDA Approved
5/12/2017
TE Code
AO
On Market Since
11/15/2017
Pharmacological Classes
Price Statistics
The NADAC for HALOPERIDOL DEC 100 MG/ML VIAL has been published 186 times since Feb 28, 2018, and over the history we have for it it has declined 84.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.5241 per ML |
|---|---|
| All-time high | $49.6320 (Mar 14, 2018) |
| All-time low | $7.4315 (Jul 22, 2026) |
| 52-week high | $9.0916 |
| 52-week low | $7.4315 |
| Median price | $12.7981 |
| Average price | $18.7113 |
| Largest weekly change | -70.7% (Apr 17, 2024) |
| Weeks tracked | 186 |
| Tracking since | Feb 28, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the haloperidol decanoate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sagent Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
haloperidol decanoate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Typical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HALOPERIDOL DEC 100 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for HALOPERIDOL DEC 100 MG/ML VIAL, manufactured by Sagent Pharmaceuticals, is $7.5241 per ML (NDC 25021083301), effective Sep 30, 2026.
How has the price of HALOPERIDOL DEC 100 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for HALOPERIDOL DEC 100 MG/ML VIAL has declined 84.8%. It has been tracked across 186 weekly CMS publications since Feb 28, 2018.
What are the highest and lowest recorded NADAC prices for HALOPERIDOL DEC 100 MG/ML VIAL?
Since Feb 28, 2018, the NADAC for HALOPERIDOL DEC 100 MG/ML VIAL has ranged from a low of $7.4315 (Jul 22, 2026) to a high of $49.6320 (Mar 14, 2018), with a median of $12.7981 per ML.
Are there cheaper alternatives to HALOPERIDOL DEC 100 MG/ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of HALOPERIDOL DEC 100 MG/ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HALOPERIDOL DEC 100 MG/ML VIAL?
HALOPERIDOL DEC 100 MG/ML VIAL (NDC 25021083301) is labeled by Sagent Pharmaceuticals, and CMS classifies it as a generic product.